CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
We are very excited to launch our new website! Please take a few moments to click around and explore...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...